Novel Treatments for Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome)

Publisher： Karger

E-ISSN： 1423-0097|136|3|205-216

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.136, Iss.3, 2005-03, pp. : 205-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteomic Kinetic Analysis of Blister Fluid and Serum in a Patient with Drug-Induced Toxic Epidermal Necrolysis. A Comparison with Skin Immunohistochemistry

By  

Current Drug Safety, Vol. 7, Iss. 5, 2012-11 ,pp. : 339-351

Bentham Science Publishers

Access to resources Recommend Favorite

A Case of Toxic Epidermal Necrolysis‐Type Drug Eruption Induced by Oral Lysozyme Chloride

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 6, 2000-06 ,pp. : 401-404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Toxic Epidermal Necrolysis

By  

Current Drug Safety, Vol. 7, Iss. 5, 2012-11 ,pp. : 332-338

Bentham Science Publishers

Access to resources Recommend Favorite

Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 3, 2018-03 ,pp. : 390-394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis

By Lee H.   Lie D.   Lim K.   Thirumoorthy T.   Pang S.  

Osteoporosis International, Vol. 20, Iss. 1, 2009-01 ,pp. : 161-162

Springer Publishing Company

Access to resources Recommend Favorite